Who is getting tested for obstructive sleep apnea using a portable recording system? Test results from 193,221 patients

Abstract

Study Objectives: To address some of the questions about "who" has been tested for OSA (in terms of pretest risk and study outcomes) using a leading national portable recorder (PR; "home sleep test"). Design: This was a retrospective analysis of a large repository of de-identifi ed test results and pretest OSA risk from 2009 to 2013. Measurements and Results: The fi nal sample was predominately male (59%), middle-aged (53.5 ± 14.2 years), obese (BMI > 30; 54%), with a large neck circumference (males = 16.9 ± 1.2 in; females = 15.0 ± 1.3 in) and a mild degree of reported sleepiness (ESS 8.7 ± 5.3). Approximately 50% of the sample endorsed a history of hypertension. The majority of patients (89.6%) were at a high risk for OSA as assessed by the ARES screening questionnaire. Of this group, 79.9% had an AHI = 5 (MAHI = 18.2 ± 18.1) and 98% had an RDI = 5 (MRDI = 28.0 ± 19.6). The majority of patients (~60%) that screened at no apparent risk for OSA indeed had AHIs < 5 events/h. Those with a high pretest risk for OSA but low test outcomes (AHI < 5) were twice as likely to be female and approximately 20% to 30% more likely to report a history of insomnia, lung disease, and/or stroke. Setting and Patients: A total of 244,602 patients were referred for testing from a variety of clinical practices across North America. A total of 193,221 studies were included in the fi nal analyses. Interventions: NA. Conclusions: The majority of PR has been conducted on patients with a high degree of suspicion for OSA. These data suggest that PR has been used in patients with a high pretest probability of OSA. Patients with a history of insomnia, stroke, and/or lung disease may especially benefi t by a comprehensive evaluation by a physician trained in sleep medicine, especially if PR results are negative for OSA. Future studies should evaluate the utility of gender-appropriate screening measures. Although questionnaire-based screening is helpful in determining OSA risk, it is imperative that it be used in conjunction with clinical decision-making.